Role of HGF in obesity-associated tumorigenesis: C3(1)-T_Ag mice as a model for human basal-like breast cancer

go back to reference Thiebaut AC, Kipnis V, Chang SC, Subar AF, Thompson FE, Rosenberg PS, Hollenbeck AR, Leitzmann M, Schatzkin A (2007) Dietary fat and postmenopausal invasive breast cancer in the National Institutes of Health-AARP Diet and Health Study cohort. J Natl Cancer Inst 99(6):451–462. doi:10.1093/jnci/djk094 PubMedCrossRef Thiebaut AC, Kipnis V, Chang SC, Subar AF, Thompson FE, Rosenberg PS, Hollenbeck AR, Leitzmann M, Schatzkin A (2007) Dietary fat and postmenopausal invasive breast cancer in the National Institutes of Health-AARP Diet and Health Study cohort. J Natl Cancer Inst 99(6):451–462. doi:10.​1093/​jnci/​djk094 PubMedCrossRef

go back to reference Sundaram S, Johnson AR, Makowski L (2013) Obesity, metabolism and the microenvironment: links to cancer. J Carcinog 12:19 Sundaram S, Johnson AR, Makowski L (2013) Obesity, metabolism and the microenvironment: links to cancer. J Carcinog 12:19

go back to reference Cecchini RS, Costantino JP, Cauley JA, Cronin WM, Wickerham DL, Land SR, Weissfeld JL, Wolmark N (2012) Body mass index and the risk for developing invasive breast cancer among high-risk women in NSABP P-1 and STAR breast cancer prevention trials. Cancer Prev Res (Phila) 5(4):583–592. doi:10.1158/1940-6207.CAPR-11-0482 CrossRef Cecchini RS, Costantino JP, Cauley JA, Cronin WM, Wickerham DL, Land SR, Weissfeld JL, Wolmark N (2012) Body mass index and the risk for developing invasive breast cancer among high-risk women in NSABP P-1 and STAR breast cancer prevention trials. Cancer Prev Res (Phila) 5(4):583–592. doi:10.​1158/​1940-6207.​CAPR-11-0482 CrossRef

go back to reference Anderson GL, Neuhouser ML (2012) Obesity and the Risk for Premenopausal and Postmenopausal Breast Cancer. Cancer Prev Res 5(4):515–521. doi:10.1158/1940-6207.capr-12-0091 CrossRef Anderson GL, Neuhouser ML (2012) Obesity and the Risk for Premenopausal and Postmenopausal Breast Cancer. Cancer Prev Res 5(4):515–521. doi:10.​1158/​1940-6207.​capr-12-0091 CrossRef

go back to reference Yang XR, Chang-Claude J, Goode EL, Couch FJ, Nevanlinna H, Milne RL, Gaudet M, Schmidt MK, Broeks A, Cox A, Fasching PA, Hein R, Spurdle AB, Blows F, Driver K, Flesch-Janys D, Heinz J, Sinn P, Vrieling A, Heikkinen T, Aittomaki K, Heikkila P, Blomqvist C, Lissowska J, Peplonska B, Chanock S, Figueroa J, Brinton L, Hall P, Czene K, Humphreys K, Darabi H, Liu J, Van ‘t Veer LJ, van Leeuwen FE, Andrulis IL, Glendon G, Knight JA, Mulligan AM, O’Malley FP, Weerasooriya N, John EM, Beckmann MW, Hartmann A, Weihbrecht SB, Wachter DL, Jud SM, Loehberg CR, Baglietto L, English DR, Giles GG, McLean CA, Severi G, Lambrechts D, Vandorpe T, Weltens C, Paridaens R, Smeets A, Neven P, Wildiers H, Wang X, Olson JE, Cafourek V, Fredericksen Z, Kosel M, Vachon C, Cramp HE, Connley D, Cross SS, Balasubramanian SP, Reed MW, Dork T, Bremer M, Meyer A, Karstens JH, Ay A, Park-Simon TW, Hillemanns P, Arias Perez JI, Menendez Rodriguez P, Zamora P, Benitez J, Ko YD, Fischer HP, Hamann U, Pesch B, Bruning T, Justenhoven C, Brauch H, Eccles DM, Tapper WJ, Gerty SM, Sawyer EJ, Tomlinson IP, Jones A, Kerin M, Miller N, McInerney N, Anton-Culver H, Ziogas A, Shen CY, Hsiung CN, Wu PE, Yang SL, Yu JC, Chen ST, Hsu GC, Haiman CA, Henderson BE, Le Marchand L, Kolonel LN, Lindblom A, Margolin S, Jakubowska A, Lubinski J, Huzarski T, Byrski T, Gorski B, Gronwald J, Hooning MJ, Hollestelle A, van den Ouweland AM, Jager A, Kriege M, Tilanus-Linthorst MM, Collee M, Wang-Gohrke S, Pylkas K, Jukkola-Vuorinen A, Mononen K, Grip M, Hirvikoski P, Winqvist R, Mannermaa A, Kosma VM, Kauppinen J, Kataja V, Auvinen P, Soini Y, Sironen R, Bojesen SE, Orsted DD, Kaur-Knudsen D, Flyger H, Nordestgaard BG, Holland H, Chenevix-Trench G, Manoukian S, Barile M, Radice P, Hankinson SE, Hunter DJ, Tamimi R, Sangrajrang S, Brennan P, McKay J, Odefrey F, Gaborieau V, Devilee P, Huijts PE, Tollenaar RA, Seynaeve C, Dite GS, Apicella C, Hopper JL, Hammet F, Tsimiklis H, Smith LD, Southey MC, Humphreys MK, Easton D, Pharoah P, Sherman ME, Garcia-Closas M (2011) Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. J Nat Cancer Inst 103(3):250–263. doi:10.1093/jnci/djq526 Yang XR, Chang-Claude J, Goode EL, Couch FJ, Nevanlinna H, Milne RL, Gaudet M, Schmidt MK, Broeks A, Cox A, Fasching PA, Hein R, Spurdle AB, Blows F, Driver K, Flesch-Janys D, Heinz J, Sinn P, Vrieling A, Heikkinen T, Aittomaki K, Heikkila P, Blomqvist C, Lissowska J, Peplonska B, Chanock S, Figueroa J, Brinton L, Hall P, Czene K, Humphreys K, Darabi H, Liu J, Van ‘t Veer LJ, van Leeuwen FE, Andrulis IL, Glendon G, Knight JA, Mulligan AM, O’Malley FP, Weerasooriya N, John EM, Beckmann MW, Hartmann A, Weihbrecht SB, Wachter DL, Jud SM, Loehberg CR, Baglietto L, English DR, Giles GG, McLean CA, Severi G, Lambrechts D, Vandorpe T, Weltens C, Paridaens R, Smeets A, Neven P, Wildiers H, Wang X, Olson JE, Cafourek V, Fredericksen Z, Kosel M, Vachon C, Cramp HE, Connley D, Cross SS, Balasubramanian SP, Reed MW, Dork T, Bremer M, Meyer A, Karstens JH, Ay A, Park-Simon TW, Hillemanns P, Arias Perez JI, Menendez Rodriguez P, Zamora P, Benitez J, Ko YD, Fischer HP, Hamann U, Pesch B, Bruning T, Justenhoven C, Brauch H, Eccles DM, Tapper WJ, Gerty SM, Sawyer EJ, Tomlinson IP, Jones A, Kerin M, Miller N, McInerney N, Anton-Culver H, Ziogas A, Shen CY, Hsiung CN, Wu PE, Yang SL, Yu JC, Chen ST, Hsu GC, Haiman CA, Henderson BE, Le Marchand L, Kolonel LN, Lindblom A, Margolin S, Jakubowska A, Lubinski J, Huzarski T, Byrski T, Gorski B, Gronwald J, Hooning MJ, Hollestelle A, van den Ouweland AM, Jager A, Kriege M, Tilanus-Linthorst MM, Collee M, Wang-Gohrke S, Pylkas K, Jukkola-Vuorinen A, Mononen K, Grip M, Hirvikoski P, Winqvist R, Mannermaa A, Kosma VM, Kauppinen J, Kataja V, Auvinen P, Soini Y, Sironen R, Bojesen SE, Orsted DD, Kaur-Knudsen D, Flyger H, Nordestgaard BG, Holland H, Chenevix-Trench G, Manoukian S, Barile M, Radice P, Hankinson SE, Hunter DJ, Tamimi R, Sangrajrang S, Brennan P, McKay J, Odefrey F, Gaborieau V, Devilee P, Huijts PE, Tollenaar RA, Seynaeve C, Dite GS, Apicella C, Hopper JL, Hammet F, Tsimiklis H, Smith LD, Southey MC, Humphreys MK, Easton D, Pharoah P, Sherman ME, Garcia-Closas M (2011) Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. J Nat Cancer Inst 103(3):250–263. doi:10.​1093/​jnci/​djq526

go back to reference Kapur K, Jiang H, Xing Y, Wong W (2008) Cross-hybridization modeling on Affymetrix exon arrays. Bioinformatics 24:2887–2893PubMedCrossRef Kapur K, Jiang H, Xing Y, Wong W (2008) Cross-hybridization modeling on Affymetrix exon arrays. Bioinformatics 24:2887–2893PubMedCrossRef

go back to reference Calle EE, Kaaks R (2004) Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 4(8):579–591. doi:10.1038/nrc1408 PubMedCrossRef Calle EE, Kaaks R (2004) Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 4(8):579–591. doi:10.​1038/​nrc1408 PubMedCrossRef

go back to reference Reeves KW, Faulkner K, Modugno F, Hillier TA, Bauer DC, Ensrud KE, Cauley JA (2007) Body mass index and mortality among older breast cancer survivors in the study of osteoporotic fractures. Cancer Epidemiol Biomarkers Prev 16(7):1468–1473. doi:10.1158/1055-9965.EPI-07-0051 PubMedCrossRef Reeves KW, Faulkner K, Modugno F, Hillier TA, Bauer DC, Ensrud KE, Cauley JA (2007) Body mass index and mortality among older breast cancer survivors in the study of osteoporotic fractures. Cancer Epidemiol Biomarkers Prev 16(7):1468–1473. doi:10.​1158/​1055-9965.​EPI-07-0051 PubMedCrossRef

go back to reference Sieri S, Krogh V, Ferrari P, Berrino F, Pala V, Thiebaut AC, Tjonneland A, Olsen A, Overvad K, Jakobsen MU, Clavel-Chapelon F, Chajes V, Boutron-Ruault MC, Kaaks R, Linseisen J, Boeing H, Nothlings U, Trichopoulou A, Naska A, Lagiou P, Panico S, Palli D, Vineis P, Tumino R, Lund E, Kumle M, Skeie G, Gonzalez CA, Ardanaz E, Amiano P, Tormo MJ, Martinez-Garcia C, Quiros JR, Berglund G, Gullberg B, Hallmans G, Lenner P, Bueno-de-Mesquita HB, van Duijnhoven FJ, Peeters PH, van Gils CH, Key TJ, Crowe FL, Bingham S, Khaw KT, Rinaldi S, Slimani N, Jenab M, Norat T, Riboli E (2008) Dietary fat and breast cancer risk in the European prospective investigation into cancer and nutrition. Am J Clin Nutr 88(5):1304–1312PubMed Sieri S, Krogh V, Ferrari P, Berrino F, Pala V, Thiebaut AC, Tjonneland A, Olsen A, Overvad K, Jakobsen MU, Clavel-Chapelon F, Chajes V, Boutron-Ruault MC, Kaaks R, Linseisen J, Boeing H, Nothlings U, Trichopoulou A, Naska A, Lagiou P, Panico S, Palli D, Vineis P, Tumino R, Lund E, Kumle M, Skeie G, Gonzalez CA, Ardanaz E, Amiano P, Tormo MJ, Martinez-Garcia C, Quiros JR, Berglund G, Gullberg B, Hallmans G, Lenner P, Bueno-de-Mesquita HB, van Duijnhoven FJ, Peeters PH, van Gils CH, Key TJ, Crowe FL, Bingham S, Khaw KT, Rinaldi S, Slimani N, Jenab M, Norat T, Riboli E (2008) Dietary fat and breast cancer risk in the European prospective investigation into cancer and nutrition. Am J Clin Nutr 88(5):1304–1312PubMed

go back to reference Toft DJ, Cryns VL (2011) Minireview: basal-like breast cancer: from molecular profiles to targeted therapies. Mol Endocrinol 25(2):199–211. doi:10.1210/me.2010-0164 PubMedCrossRef Toft DJ, Cryns VL (2011) Minireview: basal-like breast cancer: from molecular profiles to targeted therapies. Mol Endocrinol 25(2):199–211. doi:10.​1210/​me.​2010-0164 PubMedCrossRef

go back to reference Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, Conway K, Karaca G, Troester MA, Tse CK, Edmiston S, Deming SL, Geradts J, Cheang MC, Nielsen TO, Moorman PG, Earp HS, Millikan RC (2006) Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 295(21):2492–2502. doi:10.1001/jama.295.21.2492 PubMedCrossRef Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, Conway K, Karaca G, Troester MA, Tse CK, Edmiston S, Deming SL, Geradts J, Cheang MC, Nielsen TO, Moorman PG, Earp HS, Millikan RC (2006) Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 295(21):2492–2502. doi:10.​1001/​jama.​295.​21.​2492 PubMedCrossRef

go back to reference Millikan RC, Newman B, Tse CK, Moorman PG, Conway K, Dressler LG, Smith LV, Labbok MH, Geradts J, Bensen JT, Jackson S, Nyante S, Livasy C, Carey L, Earp HS, Perou CM (2008) Epidemiology of basal-like breast cancer. Breast Cancer Res Treat 109(1):123–139. doi:10.1007/s10549-007-9632-6 PubMedCrossRef Millikan RC, Newman B, Tse CK, Moorman PG, Conway K, Dressler LG, Smith LV, Labbok MH, Geradts J, Bensen JT, Jackson S, Nyante S, Livasy C, Carey L, Earp HS, Perou CM (2008) Epidemiology of basal-like breast cancer. Breast Cancer Res Treat 109(1):123–139. doi:10.​1007/​s10549-007-9632-6 PubMedCrossRef

go back to reference Boggs DA, Rosenberg L, Cozier YC, Wise LA, Coogan PF, Ruiz-Narvaez EA, Palmer JR (2011) General and abdominal obesity and risk of death among black women. New Engl J Med 365(10):901–908. doi:10.1056/NEJMoa1104119 PubMedCrossRef Boggs DA, Rosenberg L, Cozier YC, Wise LA, Coogan PF, Ruiz-Narvaez EA, Palmer JR (2011) General and abdominal obesity and risk of death among black women. New Engl J Med 365(10):901–908. doi:10.​1056/​NEJMoa1104119 PubMedCrossRef

go back to reference Keppel KG, Taffel SM (1993) Pregnancy-related weight gain and retention: implications of the 1990 Institute of medicine guidelines. Am J Public Health 83(8):1100–1103PubMedCrossRef Keppel KG, Taffel SM (1993) Pregnancy-related weight gain and retention: implications of the 1990 Institute of medicine guidelines. Am J Public Health 83(8):1100–1103PubMedCrossRef

go back to reference Olson LK, Tan Y, Zhao Y, Aupperlee MD, Haslam SZ (2010) Pubertal exposure to high fat diet causes mouse strain-dependent alterations in mammary gland development and estrogen responsiveness. Int J Obes (Lond) 34(9):1415–1426. doi:10.1038/ijo.2010.51 CrossRef Olson LK, Tan Y, Zhao Y, Aupperlee MD, Haslam SZ (2010) Pubertal exposure to high fat diet causes mouse strain-dependent alterations in mammary gland development and estrogen responsiveness. Int J Obes (Lond) 34(9):1415–1426. doi:10.​1038/​ijo.​2010.​51 CrossRef

go back to reference Hue-Beauvais C, Chavatte-Palmer P, Aujean E, Dahirel M, Laigre P, Pechoux C, Bouet S, Devinoy E, Charlier M (2011) An obesogenic diet started before puberty leads to abnormal mammary gland development during pregnancy in the rabbit. Dev Dyn 240(2):347–356. doi:10.1002/dvdy.22536 PubMedCrossRef Hue-Beauvais C, Chavatte-Palmer P, Aujean E, Dahirel M, Laigre P, Pechoux C, Bouet S, Devinoy E, Charlier M (2011) An obesogenic diet started before puberty leads to abnormal mammary gland development during pregnancy in the rabbit. Dev Dyn 240(2):347–356. doi:10.​1002/​dvdy.​22536 PubMedCrossRef

go back to reference Gordon RR, Hunter KW, La Merrill M, Sorensen P, Threadgill DW, Pomp D (2008) Genotype X diet interactions in mice predisposed to mammary cancer: II. Tumors and metastasis. Mamm Genome 19(3):179–189. doi:10.1007/s00335-008-9096-y Gordon RR, Hunter KW, La Merrill M, Sorensen P, Threadgill DW, Pomp D (2008) Genotype X diet interactions in mice predisposed to mammary cancer: II. Tumors and metastasis. Mamm Genome 19(3):179–189. doi:10.​1007/​s00335-008-9096-y

go back to reference Flegal KM, Carroll MD, Kit BK, Ogden CL (2012) Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999–2010. JAMA 307(5):491–497. doi:10.1001/jama.2012.39 PubMedCrossRef Flegal KM, Carroll MD, Kit BK, Ogden CL (2012) Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999–2010. JAMA 307(5):491–497. doi:10.​1001/​jama.​2012.​39 PubMedCrossRef

go back to reference Casbas-Hernandez P, Fleming JM, Troester M (2011) Gene expression analysis of in vitro co-cultures to study interactions between breast epithelium and stroma. J Biomed Biotechnol 2011:520987. doi:10.1155/2011/520987 Casbas-Hernandez P, Fleming JM, Troester M (2011) Gene expression analysis of in vitro co-cultures to study interactions between breast epithelium and stroma. J Biomed Biotechnol 2011:520987. doi:10.​1155/​2011/​520987

go back to reference Le TT, Rehrer CW, Huff TB, Nichols MB, Camarillo IG, Ji-Xin C (2007) Nonlinear optical imaging to evaluate the impact of obesity on mammary gland and tumor stroma. Mol Imag 6(3):204–205. doi:10.2310/7290.2007.00018 Le TT, Rehrer CW, Huff TB, Nichols MB, Camarillo IG, Ji-Xin C (2007) Nonlinear optical imaging to evaluate the impact of obesity on mammary gland and tumor stroma. Mol Imag 6(3):204–205. doi:10.​2310/​7290.​2007.​00018

go back to reference Sinicrope FA, Dannenberg AJ (2011) Obesity and breast cancer prognosis: weight of the evidence. J Clin Oncol 29(1):4–7. doi:10.1200/JCO.2010.32.1752 PubMedCrossRef Sinicrope FA, Dannenberg AJ (2011) Obesity and breast cancer prognosis: weight of the evidence. J Clin Oncol 29(1):4–7. doi:10.​1200/​JCO.​2010.​32.​1752 PubMedCrossRef

go back to reference Subbaramaiah K, Howe LR, Bhardwaj P, Du B, Gravaghi C, Yantiss RK, Zhou XK, Blaho VA, Hla T, Yang P, Kopelovich L, Hudis CA, Dannenberg AJ (2011) Obesity is associated with inflammation and elevated aromatase expression in the mouse mammary gland. Cancer Prev Res (Phila) 4(3):329–346. doi:10.1158/1940-6207.CAPR-10-0381 CrossRef Subbaramaiah K, Howe LR, Bhardwaj P, Du B, Gravaghi C, Yantiss RK, Zhou XK, Blaho VA, Hla T, Yang P, Kopelovich L, Hudis CA, Dannenberg AJ (2011) Obesity is associated with inflammation and elevated aromatase expression in the mouse mammary gland. Cancer Prev Res (Phila) 4(3):329–346. doi:10.​1158/​1940-6207.​CAPR-10-0381 CrossRef

go back to reference Camp JT, Elloumi F, Roman-Perez E, Rein J, Stewart DA, Harrell JC, Perou CM, Troester MA (2011) Interactions with fibroblasts are distinct in basal-like and luminal breast cancers. Mol Cancer Res 9(1):3–13. doi:10.1158/1541-7786.MCR-10-0372 PubMedCrossRef Camp JT, Elloumi F, Roman-Perez E, Rein J, Stewart DA, Harrell JC, Perou CM, Troester MA (2011) Interactions with fibroblasts are distinct in basal-like and luminal breast cancers. Mol Cancer Res 9(1):3–13. doi:10.​1158/​1541-7786.​MCR-10-0372 PubMedCrossRef

go back to reference Xu K, Usary J, Kousis Philaretos C, Prat A, Wang D-Y, Adams Jessica R, Wang W, Loch Amanda J, Deng T, Zhao W, Cardiff Robert D, Yoon K, Gaiano N, Ling V, Beyene J, Zacksenhaus E, Gridley T, Leong Wey L, Guidos Cynthia J, Perou Charles M, Egan Sean E (2012) Lunatic fringe deficiency cooperates with the Met/Caveolin gene amplicon to induce basal-like breast cancer. Cancer Cell 21(5):626–641. doi:10.1016/j.ccr.2012.03.041 PubMedCrossRef Xu K, Usary J, Kousis Philaretos C, Prat A, Wang D-Y, Adams Jessica R, Wang W, Loch Amanda J, Deng T, Zhao W, Cardiff Robert D, Yoon K, Gaiano N, Ling V, Beyene J, Zacksenhaus E, Gridley T, Leong Wey L, Guidos Cynthia J, Perou Charles M, Egan Sean E (2012) Lunatic fringe deficiency cooperates with the Met/Caveolin gene amplicon to induce basal-like breast cancer. Cancer Cell 21(5):626–641. doi:10.​1016/​j.​ccr.​2012.​03.​041 PubMedCrossRef

go back to reference Gastaldi S, Sassi F, Accornero P, Torti D, Galimi F, Migliardi G, Molyneux G, Perera T, Comoglio PM, Boccaccio C, Smalley MJ, Bertotti A, Trusolino L (2012) Met signaling regulates growth, repopulating potential and basal cell-fate commitment of mammary luminal progenitors: implications for basal-like breast cancer. Oncogene 32(11):1428–1440. doi:10.1038/onc.2012.154 Gastaldi S, Sassi F, Accornero P, Torti D, Galimi F, Migliardi G, Molyneux G, Perera T, Comoglio PM, Boccaccio C, Smalley MJ, Bertotti A, Trusolino L (2012) Met signaling regulates growth, repopulating potential and basal cell-fate commitment of mammary luminal progenitors: implications for basal-like breast cancer. Oncogene 32(11):1428–1440. doi:10.​1038/​onc.​2012.​154

go back to reference Rehman J, Traktuev D, Li J, Merfeld-Clauss S, Temm-Grove CJ, Bovenkerk JE, Pell CL, Johnstone BH, Considine RV, March KL (2004) Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation 109(10):1292–1298. doi:10.1161/01.cir.0000121425.42966.f1 PubMedCrossRef Rehman J, Traktuev D, Li J, Merfeld-Clauss S, Temm-Grove CJ, Bovenkerk JE, Pell CL, Johnstone BH, Considine RV, March KL (2004) Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation 109(10):1292–1298. doi:10.​1161/​01.​cir.​0000121425.​42966.​f1 PubMedCrossRef

go back to reference Bell LN, Ward JL, Degawa-Yamauchi M, Bovenkerk JE, Jones R, Cacucci BM, Gupta CE, Sheridan C, Sheridan K, Shankar SS, Steinberg HO, March KL, Considine RV (2006) Adipose tissue production of hepatocyte growth factor contributes to elevated serum HGF in obesity. Am J Physiol 291(4):E843–E848. doi:10.1152/ajpendo.0 0174.2006 Bell LN, Ward JL, Degawa-Yamauchi M, Bovenkerk JE, Jones R, Cacucci BM, Gupta CE, Sheridan C, Sheridan K, Shankar SS, Steinberg HO, March KL, Considine RV (2006) Adipose tissue production of hepatocyte growth factor contributes to elevated serum HGF in obesity. Am J Physiol 291(4):E843–E848. doi:10.​1152/​ajpendo.​0 0174.2006

go back to reference Toi M, Taniguchi T, Ueno T, Asano M, Funata N, Sekiguchi K, Iwanari H, Tominaga T (1998) Significance of circulating hepatocyte growth factor level as a prognostic indicator in primary breast cancer. Clin Cancer Res 4(3):659–664PubMed Toi M, Taniguchi T, Ueno T, Asano M, Funata N, Sekiguchi K, Iwanari H, Tominaga T (1998) Significance of circulating hepatocyte growth factor level as a prognostic indicator in primary breast cancer. Clin Cancer Res 4(3):659–664PubMed

go back to reference Sheen-Chen SM, Liu YW, Eng HL, Chou FF (2005) Serum levels of hepatocyte growth factor in patients with breast cancer. Cancer Epidemiol Biomarkers Prev 14(3):715–717. doi:10.1158/1055-9965.EPI-04-0340 PubMedCrossRef Sheen-Chen SM, Liu YW, Eng HL, Chou FF (2005) Serum levels of hepatocyte growth factor in patients with breast cancer. Cancer Epidemiol Biomarkers Prev 14(3):715–717. doi:10.​1158/​1055-9965.​EPI-04-0340 PubMedCrossRef

go back to reference Taniguchi T, Toi M, Inada K, Imazawa T, Yamamoto Y, Tominaga T (1995) Serum concentrations of hepatocyte growth factor in breast cancer patients. Clin Cancer Res 1(9):1031–1034PubMed Taniguchi T, Toi M, Inada K, Imazawa T, Yamamoto Y, Tominaga T (1995) Serum concentrations of hepatocyte growth factor in breast cancer patients. Clin Cancer Res 1(9):1031–1034PubMed

go back to reference Maiti B, Kundranda MN, Spiro TP, Daw HA (2010) The association of metabolic syndrome with triple-negative breast cancer. Breast Cancer Res Treat 121(2):479–483. doi:10.1007/s10549-009-0591-y PubMedCrossRef Maiti B, Kundranda MN, Spiro TP, Daw HA (2010) The association of metabolic syndrome with triple-negative breast cancer. Breast Cancer Res Treat 121(2):479–483. doi:10.​1007/​s10549-009-0591-y PubMedCrossRef

go back to reference Green JE, Shibata MA, Yoshidome K, Liu ML, Jorcyk C, Anver MR, Wigginton J, Wiltrout R, Shibata E, Kaczmarczyk S, Wang W, Liu ZY, Calvo A, Couldrey C (2000) The C3(1)/SV40 T-antigen transgenic mouse model of mammary cancer: ductal epithelial cell targeting with multistage progression to carcinoma. Oncogene 19(8):1020–1027. doi:10.1038/sj.onc.1203280 PubMedCrossRef Green JE, Shibata MA, Yoshidome K, Liu ML, Jorcyk C, Anver MR, Wigginton J, Wiltrout R, Shibata E, Kaczmarczyk S, Wang W, Liu ZY, Calvo A, Couldrey C (2000) The C3(1)/SV40 T-antigen transgenic mouse model of mammary cancer: ductal epithelial cell targeting with multistage progression to carcinoma. Oncogene 19(8):1020–1027. doi:10.​1038/​sj.​onc.​1203280 PubMedCrossRef

go back to reference Herschkowitz JI, Simin K, Weigman VJ, Mikaelian I, Usary J, Hu Z, Rasmussen KE, Jones LP, Assefnia S, Chandrasekharan S, Backlund MG, Yin Y, Khramtsov AI, Bastein R, Quackenbush J, Glazer RI, Brown PH, Green JE, Kopelovich L, Furth PA, Palazzo JP, Olopade OI, Bernard PS, Churchill GA, Van Dyke T, Perou CM (2007) Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors. Genome Biol 8(5):R76. doi:10.1186/gb-2007-8-5-r76 PubMedCrossRef Herschkowitz JI, Simin K, Weigman VJ, Mikaelian I, Usary J, Hu Z, Rasmussen KE, Jones LP, Assefnia S, Chandrasekharan S, Backlund MG, Yin Y, Khramtsov AI, Bastein R, Quackenbush J, Glazer RI, Brown PH, Green JE, Kopelovich L, Furth PA, Palazzo JP, Olopade OI, Bernard PS, Churchill GA, Van Dyke T, Perou CM (2007) Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors. Genome Biol 8(5):R76. doi:10.​1186/​gb-2007-8-5-r76 PubMedCrossRef

go back to reference Sampey BP, Vanhoose AM, Winfield HM, Freemerman AJ, Muehlbauer MJ, Fueger PT, Newgard CB, Makowski L (2011) Cafeteria diet is a robust model of human metabolic syndrome with liver and adipose inflammation: comparison to high-fat diet. Obesity (Silver Spring) 19(6):1109–1117. doi:10.1038/oby.2011.18 CrossRef Sampey BP, Vanhoose AM, Winfield HM, Freemerman AJ, Muehlbauer MJ, Fueger PT, Newgard CB, Makowski L (2011) Cafeteria diet is a robust model of human metabolic syndrome with liver and adipose inflammation: comparison to high-fat diet. Obesity (Silver Spring) 19(6):1109–1117. doi:10.​1038/​oby.​2011.​18 CrossRef

go back to reference Fleming JM, Miller TC, Kidacki M, Ginsburg E, Stuelten CH, Stewart DA, Troester MA, Vonderhaar BK (2012) Paracrine interactions between primary human macrophages and human fibroblasts enhance murine mammary gland humanization in vivo. Breast Cancer Res 14(3):R97. doi:10.1186/bcr3215 PubMedCrossRef Fleming JM, Miller TC, Kidacki M, Ginsburg E, Stuelten CH, Stewart DA, Troester MA, Vonderhaar BK (2012) Paracrine interactions between primary human macrophages and human fibroblasts enhance murine mammary gland humanization in vivo. Breast Cancer Res 14(3):R97. doi:10.​1186/​bcr3215 PubMedCrossRef

go back to reference Sampey BP, Freemerman AJ, Zhang J, Kuan PF, Galanko JA, O’Connell TM, Ilkayeva OR, Muehlbauer MJ, Stevens RD, Newgard CB, Brauer HA, Troester MA, Makowski L (2012) Metabolomic profiling reveals mitochondrial-derived lipid biomarkers that drive obesity-associated inflammation. PLoS One 7(6):e38812. doi:10.1371/journal.pone.0038812 PubMedCrossRef Sampey BP, Freemerman AJ, Zhang J, Kuan PF, Galanko JA, O’Connell TM, Ilkayeva OR, Muehlbauer MJ, Stevens RD, Newgard CB, Brauer HA, Troester MA, Makowski L (2012) Metabolomic profiling reveals mitochondrial-derived lipid biomarkers that drive obesity-associated inflammation. PLoS One 7(6):e38812. doi:10.​1371/​journal.​pone.​0038812 PubMedCrossRef

go back to reference Ponzo MG, Park M (2010) The Met receptor tyrosine kinase and basal breast cancer. Cell Cycle 9(6):1043–1050PubMedCrossRef Ponzo MG, Park M (2010) The Met receptor tyrosine kinase and basal breast cancer. Cell Cycle 9(6):1043–1050PubMedCrossRef

go back to reference Moghul A, Lin L, Beedle A, Kanbour-Shakir A, DeFrances MC, Liu Y, Zarnegar R (1994) Modulation of c-MET proto-oncogene (HGF receptor) mRNA abundance by cytokines and hormones: evidence for rapid decay of the 8 kb c-MET transcript. Oncogene 9(7):2045–2052PubMed Moghul A, Lin L, Beedle A, Kanbour-Shakir A, DeFrances MC, Liu Y, Zarnegar R (1994) Modulation of c-MET proto-oncogene (HGF receptor) mRNA abundance by cytokines and hormones: evidence for rapid decay of the 8 kb c-MET transcript. Oncogene 9(7):2045–2052PubMed

go back to reference Blumenschein GR, Mills GB, Gonzalez-Angulo AM (2012) Targeting the hepatocyte growth factor—cMET axis in cancer therapy. J Clin Oncol 30(26):3287–3296. doi:10.1200/jco.2011.40.3774 PubMedCrossRef Blumenschein GR, Mills GB, Gonzalez-Angulo AM (2012) Targeting the hepatocyte growth factor—cMET axis in cancer therapy. J Clin Oncol 30(26):3287–3296. doi:10.​1200/​jco.​2011.​40.​3774 PubMedCrossRef

go back to reference Jagadeeswaran R, Ma PC, Seiwert TY, Jagadeeswaran S, Zumba O, Nallasura V, Ahmed S, Filiberti R, Paganuzzi M, Puntoni R, Kratzke RA, Gordon GJ, Sugarbaker DJ, Bueno R, Janamanchi V, Bindokas VP, Kindler HL, Salgia R (2006) Functional analysis of c-Met/hepatocyte growth factor pathway in malignant pleural mesothelioma. Cancer Res 66(1):352–361. doi:10.1158/0008-5472.can-04-4567 PubMedCrossRef Jagadeeswaran R, Ma PC, Seiwert TY, Jagadeeswaran S, Zumba O, Nallasura V, Ahmed S, Filiberti R, Paganuzzi M, Puntoni R, Kratzke RA, Gordon GJ, Sugarbaker DJ, Bueno R, Janamanchi V, Bindokas VP, Kindler HL, Salgia R (2006) Functional analysis of c-Met/hepatocyte growth factor pathway in malignant pleural mesothelioma. Cancer Res 66(1):352–361. doi:10.​1158/​0008-5472.​can-04-4567 PubMedCrossRef

go back to reference Johnson AR, Justin Milner J, Makowski L (2012) The inflammation highway: metabolism accelerates inflammatory traffic in obesity. Immunol Rev 249(1):218–238. doi:10.1111/j.1600-065X.2012.01151.x PubMedCrossRef Johnson AR, Justin Milner J, Makowski L (2012) The inflammation highway: metabolism accelerates inflammatory traffic in obesity. Immunol Rev 249(1):218–238. doi:10.​1111/​j.​1600-065X.​2012.​01151.​x PubMedCrossRef

go back to reference Wolf I, Sadetzki S, Kanety H, Kundel Y, Pariente C, Epstein N, Oberman B, Catane R, Kaufman B, Shimon I (2006) Adiponectin, ghrelin, and leptin in cancer cachexia in breast and colon cancer patients. Cancer 106(4):966–973. doi:10.1002/cncr.21690 PubMedCrossRef Wolf I, Sadetzki S, Kanety H, Kundel Y, Pariente C, Epstein N, Oberman B, Catane R, Kaufman B, Shimon I (2006) Adiponectin, ghrelin, and leptin in cancer cachexia in breast and colon cancer patients. Cancer 106(4):966–973. doi:10.​1002/​cncr.​21690 PubMedCrossRef

go back to reference Engineer DR, Garcia JM (2012) Leptin in anorexia and cachexia syndrome. Int J Pept 2012:287457. doi:10.1155/2012/287457 Engineer DR, Garcia JM (2012) Leptin in anorexia and cachexia syndrome. Int J Pept 2012:287457. doi:10.​1155/​2012/​287457

go back to reference Smiechowska J, Utech A, Taffet G, Hayes T, Marcelli M, Garcia JM (2010) Adipokines in patients with cancer anorexia and cachexia. J Investig Med 58(3):554–559. doi:10.231/JIM.0b013e3181cf91ca PubMed Smiechowska J, Utech A, Taffet G, Hayes T, Marcelli M, Garcia JM (2010) Adipokines in patients with cancer anorexia and cachexia. J Investig Med 58(3):554–559. doi:10.​231/​JIM.​0b013e3181cf91ca​ PubMed

go back to reference Troester MA, Lee MH, Carter M, Fan C, Cowan DW, Perez ER, Pirone JR, Perou CM, Jerry DJ, Schneider SS (2009) Activation of host wound responses in breast cancer microenvironment. Clin Cancer Res 15(22):7020–7028. doi:10.1158/1078-0432.ccr-09-1126 PubMedCrossRef Troester MA, Lee MH, Carter M, Fan C, Cowan DW, Perez ER, Pirone JR, Perou CM, Jerry DJ, Schneider SS (2009) Activation of host wound responses in breast cancer microenvironment. Clin Cancer Res 15(22):7020–7028. doi:10.​1158/​1078-0432.​ccr-09-1126 PubMedCrossRef

go back to reference Stewart DA, Yang Y, Makowski L, Troester MA (2012) Basal-like breast cancer cells induce phenotypic and genomic changes in macrophages. Mol Cancer Res 10(6):727–738. doi:10.1158/1541-7786.mcr-11-0604 PubMedCrossRef Stewart DA, Yang Y, Makowski L, Troester MA (2012) Basal-like breast cancer cells induce phenotypic and genomic changes in macrophages. Mol Cancer Res 10(6):727–738. doi:10.​1158/​1541-7786.​mcr-11-0604 PubMedCrossRef

go back to reference Sun X, Gierach GL, Sandhu R, Williams T, Midkiff BR, Lissowska J, Wesolowska E, Boyd NF, Johnson NB, Figueroa JD, Sherman ME, Troester MA (2013) Relationship of mammographic density and gene expression: analysis of normal breast tissue surrounding breast cancer. Clin Cancer Res 19(18):4972–4982. doi:10.1158/1078-0432.CCR-13-0029 PubMedCrossRef Sun X, Gierach GL, Sandhu R, Williams T, Midkiff BR, Lissowska J, Wesolowska E, Boyd NF, Johnson NB, Figueroa JD, Sherman ME, Troester MA (2013) Relationship of mammographic density and gene expression: analysis of normal breast tissue surrounding breast cancer. Clin Cancer Res 19(18):4972–4982. doi:10.​1158/​1078-0432.​CCR-13-0029 PubMedCrossRef

go back to reference Roman-Perez E, Casbas-Hernandez P, Pirone JR, Rein J, Carey LA, Lubet RA, Mani SA, Amos KD, Troester MA (2012) Gene expression in extratumoral microenvironment predicts clinical outcome in breast cancer patients. Breast Cancer Res 14(2):R51. doi:10.1186/bcr3152 PubMedCrossRef Roman-Perez E, Casbas-Hernandez P, Pirone JR, Rein J, Carey LA, Lubet RA, Mani SA, Amos KD, Troester MA (2012) Gene expression in extratumoral microenvironment predicts clinical outcome in breast cancer patients. Breast Cancer Res 14(2):R51. doi:10.​1186/​bcr3152 PubMedCrossRef

go back to reference Casbas-Hernandez P, Darcy M, Roman-Perez E, Brauer H, McNaughton K, Miller S, Chhetri R, Oldenburg A, Fleming J, Amos K, Makowski L, Troester M (2013) Role of HGF in epithelial-stromal cell interactions during progression from benign breast disease to ductal carcinoma in situ. Breast Cancer Res 15(5):R82 Casbas-Hernandez P, Darcy M, Roman-Perez E, Brauer H, McNaughton K, Miller S, Chhetri R, Oldenburg A, Fleming J, Amos K, Makowski L, Troester M (2013) Role of HGF in epithelial-stromal cell interactions during progression from benign breast disease to ductal carcinoma in situ. Breast Cancer Res 15(5):R82

go back to reference Brauer HA, Makowski L, Hoadley KA, Casbas-Hernandez P, Lang LJ, Roman-Perez E, D’Arcy M, Freemerman AJ, Perou CM, Troester MA (2013) Impact of tumor microenvironment and epithelial phenotypes on metabolism in breast cancer. Clin Cancer Res 19(3):571–585. doi:10.1158/1078-0432.CCR-12-2123 PubMedCrossRef Brauer HA, Makowski L, Hoadley KA, Casbas-Hernandez P, Lang LJ, Roman-Perez E, D’Arcy M, Freemerman AJ, Perou CM, Troester MA (2013) Impact of tumor microenvironment and epithelial phenotypes on metabolism in breast cancer. Clin Cancer Res 19(3):571–585. doi:10.​1158/​1078-0432.​CCR-12-2123 PubMedCrossRef

go back to reference Davis AA, Kaklamani VG (2012) Metabolic syndrome and triple-negative breast cancer: a new paradigm. Int J Breast Cancer 2012:809291. doi:10.1155/2012/809291 Davis AA, Kaklamani VG (2012) Metabolic syndrome and triple-negative breast cancer: a new paradigm. Int J Breast Cancer 2012:809291. doi:10.​1155/​2012/​809291

go back to reference Paz-Filho G, Lim EL, Wong ML, Licinio J (2011) Associations between adipokines and obesity-related cancer. Frontiers Biosci 16:1634–1650CrossRef Paz-Filho G, Lim EL, Wong ML, Licinio J (2011) Associations between adipokines and obesity-related cancer. Frontiers Biosci 16:1634–1650CrossRef

go back to reference Saxena NK, Taliaferro-Smith L, Knight BB, Merlin D, Anania FA, O’Regan RM, Sharma D (2008) Bidirectional crosstalk between leptin and insulin-like growth factor-I signaling promotes invasion and migration of breast cancer cells via transactivation of epidermal growth factor receptor. Cancer Res 68(23):9712–9722. doi:10.1158/0008-5472.CAN-08-1952 PubMedCrossRef Saxena NK, Taliaferro-Smith L, Knight BB, Merlin D, Anania FA, O’Regan RM, Sharma D (2008) Bidirectional crosstalk between leptin and insulin-like growth factor-I signaling promotes invasion and migration of breast cancer cells via transactivation of epidermal growth factor receptor. Cancer Res 68(23):9712–9722. doi:10.​1158/​0008-5472.​CAN-08-1952 PubMedCrossRef

go back to reference Sun X, Casbas-Hernandez P, Bigelow C, Makowski L, Joseph Jerry D, Smith Schneider S, Troester MA (2012) Normal breast tissue of obese women is enriched for macrophage markers and macrophage-associated gene expression. Breast Cancer Res Treat 131(3):1003–1012. doi:10.1007/s10549-011-1789-3 PubMedCrossRef Sun X, Casbas-Hernandez P, Bigelow C, Makowski L, Joseph Jerry D, Smith Schneider S, Troester MA (2012) Normal breast tissue of obese women is enriched for macrophage markers and macrophage-associated gene expression. Breast Cancer Res Treat 131(3):1003–1012. doi:10.​1007/​s10549-011-1789-3 PubMedCrossRef

go back to reference Morris PG, Hudis CA, Giri D, Morrow M, Falcone DJ, Zhou XK, Du B, Brogi E, Crawford CB, Kopelovich L, Subbaramaiah K, Dannenberg AJ (2011) Inflammation and increased aromatase expression occur in the breast tissue of obese women with breast cancer. Cancer Prev Res 4(7):1021–1029. doi:10.1158/1940-6207.capr-11-0110 CrossRef Morris PG, Hudis CA, Giri D, Morrow M, Falcone DJ, Zhou XK, Du B, Brogi E, Crawford CB, Kopelovich L, Subbaramaiah K, Dannenberg AJ (2011) Inflammation and increased aromatase expression occur in the breast tissue of obese women with breast cancer. Cancer Prev Res 4(7):1021–1029. doi:10.​1158/​1940-6207.​capr-11-0110 CrossRef

go back to reference Yoshidome K, Shibata M-A, Couldrey C, Korach KS, Green JE (2000) Estrogen promotes mammary tumor development in C3(1)/SV40 large T-antigen transgenic mice: paradoxical loss of estrogen receptorα expression during tumor progression. Cancer Res 60(24):6901–6910PubMed Yoshidome K, Shibata M-A, Couldrey C, Korach KS, Green JE (2000) Estrogen promotes mammary tumor development in C3(1)/SV40 large T-antigen transgenic mice: paradoxical loss of estrogen receptorα expression during tumor progression. Cancer Res 60(24):6901–6910PubMed

go back to reference Cao B, Su Y, Oskarsson M, Zhao P, Kort EJ, Fisher RJ, Wang L-M, Vande Woude GF (2001) Neutralizing monoclonal antibodies to hepatocyte growth factor/scatter factor (HGF/SF) display antitumor activity in animal models. Proc Natl Acad Sci 98(13):7443–7448. doi:10.1073/pnas.131200498 PubMedCrossRef Cao B, Su Y, Oskarsson M, Zhao P, Kort EJ, Fisher RJ, Wang L-M, Vande Woude GF (2001) Neutralizing monoclonal antibodies to hepatocyte growth factor/scatter factor (HGF/SF) display antitumor activity in animal models. Proc Natl Acad Sci 98(13):7443–7448. doi:10.​1073/​pnas.​131200498 PubMedCrossRef

go back to reference Martinez-Lopez N, Varela-Rey M, Ariz U, Embade N, Vazquez-Chantada M, Fernandez-Ramos D, Gomez-Santos L, Lu SC, Mato JM, Martinez-Chantar ML (2008) S-adenosylmethionine and proliferation: new pathways, new targets. Biochem Soc Trans 36(Pt 5):848–852. doi:10.1042/BST0360848 PubMedCrossRef Martinez-Lopez N, Varela-Rey M, Ariz U, Embade N, Vazquez-Chantada M, Fernandez-Ramos D, Gomez-Santos L, Lu SC, Mato JM, Martinez-Chantar ML (2008) S-adenosylmethionine and proliferation: new pathways, new targets. Biochem Soc Trans 36(Pt 5):848–852. doi:10.​1042/​BST0360848 PubMedCrossRef

go back to reference Clinical Trials Involving HGF/SF-Met Inhibitors (2013). The data currently includes three drug categories: anti-HGF/SF antibodies, anti-Met antibodies and Met kinase inhibitors. http://www.vai.org/metclinicaltrials. Accessed 10 Oct 2013 Clinical Trials Involving HGF/SF-Met Inhibitors (2013). The data currently includes three drug categories: anti-HGF/SF antibodies, anti-Met antibodies and Met kinase inhibitors. http://​www.​vai.​org/​metclinicaltrial​s. Accessed 10 Oct 2013